{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T09:16:35Z","timestamp":1772615795553,"version":"3.50.1"},"reference-count":22,"publisher":"Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v102.2417","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T06:47:43Z","timestamp":1657608463000},"page":"adv00752","source":"Crossref","is-referenced-by-count":6,"title":["YAP1-NUTM1 Gene Fusion in Eccrine Porocarcinoma with Late Metastatic Recurrence: A Case Report"],"prefix":"10.2340","volume":"102","author":[{"given":"Sara","family":"Tormo-Mainar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Salido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon M.","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Deza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"20262","doi-asserted-by":"crossref","unstructured":"Nazemi A, Higgins S, Swift R, In G, Miller K, Wysong A. Eccrine porocarcinoma: new insights and a systematic review of the literature. Dermatol Surg 2018; 44: 1247-1261.","DOI":"10.1097\/DSS.0000000000001566"},{"key":"20263","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/DSS.0000000000001566","DOI":"10.1097\/DSS.0000000000001566"},{"key":"20264","doi-asserted-by":"crossref","unstructured":"Salih AM, Kakamad FH, Baba HO, Salih RQ, Hawbash MR, Mohammed SH, et al. Porocarcinoma; presentation and management, a meta-analysis of 453 cases. Ann Med Surg (Lond) 2017; 20: 74-79.","DOI":"10.1016\/j.amsu.2017.06.027"},{"key":"20265","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.amsu.2017.06.027","DOI":"10.1016\/j.amsu.2017.06.027"},{"key":"20266","doi-asserted-by":"crossref","unstructured":"Sekine S, Kiyono T, Ryo E, Ogawa R, Wakai S, Ichikawa H, et al. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma. J Clin Invest 2019; 129: 3827-3832.","DOI":"10.1172\/JCI126185"},{"key":"20267","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1172\/JCI126185","DOI":"10.1172\/JCI126185"},{"key":"20268","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Zubiaur A, Medina-Montalvo S, V\u00e9lez-Vel\u00e1zquez MD, Polo-Rodr\u00edguez I. Eccrine porocarcinoma: patient characteristics, clinical and histopathologic features, and treatment in 7 cases. Actas Dermosifiliogr 2017; 108: e27-e32.","DOI":"10.1016\/j.adengl.2017.03.002"},{"key":"20269","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.adengl.2017.03.002","DOI":"10.1016\/j.adengl.2017.03.002"},{"key":"20270","doi-asserted-by":"crossref","unstructured":"Macagno N, Kervarrec T, Sohier P, Poirot B, Haffner A, Carlotti A, et al. NUT Is a specific immunohistochemical marker for the diagnosis of yap1-nutm1-rearranged cutaneous poroid neoplasms. Am J Surg Pathol 2021; 45: 1221-1227.","DOI":"10.1097\/PAS.0000000000001693"},{"key":"20271","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/PAS.0000000000001693","DOI":"10.1097\/PAS.0000000000001693"},{"key":"20272","doi-asserted-by":"crossref","unstructured":"Prieto-Granada C, Morlote D, Pavlidakey P, Rodriguez-Waitkus P, Ramirez C, Florento E, et al. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: a series of six YAP1-rearranged adnexal skin tumors. J Cutan Pathol 2021; 48: 1139-1149.","DOI":"10.1111\/cup.14008"},{"key":"20273","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/cup.14008","DOI":"10.1111\/cup.14008"},{"key":"20274","doi-asserted-by":"crossref","unstructured":"Parra O, Kerr DA, Bridge JA, Loehrer AP, Linos K. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility. J Cutan Pathol 2021; 48: 95-101.","DOI":"10.1111\/cup.13832"},{"key":"20275","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/cup.13832","DOI":"10.1111\/cup.13832"},{"key":"20276","doi-asserted-by":"crossref","unstructured":"Russell-Goldman E, Hornick JL, Hanna J. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma. J Cutan Pathol 2021; 48: 403-410.","DOI":"10.1111\/cup.13924"},{"key":"20277","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/cup.13924","DOI":"10.1111\/cup.13924"},{"key":"20278","doi-asserted-by":"crossref","unstructured":"Godillot C, Boulinguez S, Riffaud L, Sibaud V, Chira C, Tournier E, et al. Complete response of a metastatic porocarcinoma treated with paclitaxel, cetuximab and radiotherapy. Eur J Cancer 2018; 90: 142-145.","DOI":"10.1016\/j.ejca.2017.11.009"},{"key":"20279","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ejca.2017.11.009","DOI":"10.1016\/j.ejca.2017.11.009"},{"key":"20280","doi-asserted-by":"crossref","unstructured":"Belin E, Ezzedine K, Stanislas S, Lalanne N, Beylot-Barry M, Taieb A, et al. Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure. Br J Dermatol 2011; 165: 985-989.","DOI":"10.1111\/j.1365-2133.2011.10486.x"},{"key":"20281","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10486.x","DOI":"10.1111\/j.1365-2133.2011.10486.x"},{"key":"20282","doi-asserted-by":"crossref","unstructured":"Lee KA, Cioni M, Robson A, Bataille V. Metastatic porocarcinoma achieving complete radiological and clinical response with pembrolizumab. BMJ Case Rep 2019; 12: e228917.","DOI":"10.1136\/bcr-2018-228917"},{"key":"20283","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bcr-2018-228917","DOI":"10.1136\/bcr-2018-228917"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/2417\/6551","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/2417\/6552","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/2417\/6551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T08:20:13Z","timestamp":1658823613000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/2417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":22,"URL":"https:\/\/doi.org\/10.2340\/actadv.v102.2417","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,26]]}}}